Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 406โ€“420 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3420
FSHB Gene (Follicle-Stimulating Hormone Beta Subunit) Deficiency Test

This test evaluates the FSHB gene for pathogenic variants associated with isolated FSH deficiency and hypogonadotropic hypogonadism.

Whole Blood (EDTA) or Extracted DNA 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the FSHB gene", "Copy number analysis of the FSHB gene"]
Parameters
[{"name": "FSHB Gene Sequencing", "reference_range": null}, {"name": "Copy Number Analysis", "reference_range": null}]
Preparation
["No fasting required", "Mandatory genetic counselling session before sample collection", "Provide detailed medical history and family pedigree chart"]
Indications
["Diagnosis of isolated FSH deficiency", "Evaluation of hypogonadotropic hypogonadism", "Family planning for individuals with FSHB-related conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21658-6 ICD-10: E23.0
Clinical summary
This test evaluates the FSHB gene for pathogenic variants associated with isolated FSH deficiency and hypogonadotropic hypogonadism.
TEST-3429
FSHR Gene Ovarian Dysgenesis Type 1 Genetic Test

This genetic test evaluates the FSHR gene for pathogenic variants associated with ovarian dysgenesis type 1.

Peripheral Blood (Whole Blood) or Buccal Swab (DNA) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["FSHR gene mutations", "Pathogenic variants"]
Parameters
[]
Preparation
[]
Indications
["Clinical signs suggesting ovarian dysgenesis", "Strong family history of ovarian dysgenesis", "Primary amenorrhea", "Infertility"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21634-7 ICD-10: Q50.3
Clinical summary
This genetic test evaluates the FSHR gene for pathogenic variants associated with ovarian dysgenesis type 1.
TEST-6185
G6PC2 Gene Hyperinsulinaemia Genetic Test

This genetic test identifies pathogenic variants in the G6PC2 gene associated with congenital hyperinsulinism.

Whole Blood (3 mL), FTA Card Blood Spot, or Extracted DNA 21โ€“28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the G6PC2 gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "No specific fasting required for sample collection"]
Indications
["Documented non-ketotic hypoglycaemia", "Family history of congenital hyperinsulinism (CHI)", "Unclear response to diazoxide therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E16.1
Clinical summary
This genetic test identifies pathogenic variants in the G6PC2 gene associated with congenital hyperinsulinism.
TEST-6379
G6PD Deficiency (Favism) Susceptibility Genetic Test

This genetic test identifies variants in the G6PD gene associated with favism, a condition causing hemolytic anemia upon exposure to specific triggers.

Whole Blood (peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["G6PD gene variants", "Susceptibility to favism"]
Parameters
[]
Preparation
["No fasting or special preparation required", "Mandatory pre-test genetic counselling session"]
Indications
["Family history of G6PD deficiency", "Suspicion of favism", "Screening individuals at risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82794-6 ICD-10: D55.0
Clinical summary
This genetic test identifies variants in the G6PD gene associated with favism, a condition causing hemolytic anemia upon exposure to specific triggers.
TEST-3283
G6PD Gene (Favism) Susceptibility Genetic Test

This test evaluates the G6PD gene for pathogenic variants associated with G6PD deficiency, a condition causing red blood cell breakdown.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["G6PD gene sequence", "Pathogenic variants in G6PD gene"]
Parameters
[]
Preparation
["No fasting required", "Brief genetic counseling session recommended prior to sample collection"]
Indications
["Family history of G6PD deficiency", "Unexplained hemolytic anemia", "Pre-exposure screening for triggering drugs/foods", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96512-1 ICD-10: D55.0, Z13.89
Clinical summary
This test evaluates the G6PD gene for pathogenic variants associated with G6PD deficiency, a condition causing red blood cell breakdown.
TEST-5937
GAA Gene Pompe Disease Genetic Test

This genetic test identifies pathogenic variants in the GAA gene, confirming a diagnosis of Pompe disease (glycogen storage disease type II). It provides crucial information for gu...

Peripheral whole blood, FTA card, or extracted DNA 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GAA gene pathogenic variants", "Cryptic splice-site variants", "Large deletions"]
Parameters
[]
Preparation
[]
Indications
["Suspected Pompe disease", "Family history of Pompe disease", "Eligibility assessment for ERT", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78416-5 ICD-10: E74.02
Clinical summary
This genetic test identifies pathogenic variants in the GAA gene, confirming a diagnosis of Pompe disease (glycogen storage disease type II). It provides crucial information for guiding treatment and family screening.
TEST-1285
Gabapentin Test

This diagnostic test evaluates the concentration of gabapentin in serum or plasma to guide therapeutic drug monitoring.

Serum or Plasma (peripheral whole blood) 5โ€“7 business days from sample receipt 1,500.00 AED
View
View test specifications and preparation
What it measures
["Serum or plasma gabapentin concentration"]
Parameters
[{"name": "Gabapentin", "reference_range": "0.05 ยตg/mL limit of quantification"}]
Preparation
["Blood must be drawn exactly 2 hours after your last gabapentin dose.", "Inform the phlebotomist of all medications and supplements you are taking."]
Indications
["Therapeutic drug monitoring for epilepsy", "Therapeutic drug monitoring for neuropathic pain", "Assessing adherence to gabapentin therapy", "Investigating suspected toxicity or lack of efficacy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3531-4 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of gabapentin in serum or plasma to guide therapeutic drug monitoring.
TEST-4277
GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 Genetic Test

This test evaluates the GABRB1 gene for pathogenic variants associated with early infantile epileptic encephalopathy type 45 (EIEE45).

Peripheral whole blood or FTA blood spot 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GABRB1 gene", "Genetic mutations associated with EIEE45"]
Parameters
[]
Preparation
["Mandatory genetic counselling session required prior to testing", "Informed consent documentation required"]
Indications
["Infants presenting with drug-resistant seizures", "Suspected early infantile epileptic encephalopathy type 45 (EIEE45)", "Family history of GABRB1-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G40.4
Clinical summary
This test evaluates the GABRB1 gene for pathogenic variants associated with early infantile epileptic encephalopathy type 45 (EIEE45).
TEST-4339
GABRB3 Gene Epilepsy (Childhood Absence Type 5) Genetic Test

This test identifies mutations in the GABRB3 gene associated with childhood absence epilepsy type 5.

Whole Blood (EDTA) โ€“ Peripheral 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GABRB3 gene mutations"]
Parameters
[]
Preparation
[]
Indications
["Suspected childhood absence epilepsy type 5", "Family history of childhood absence epilepsy type 5"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G40.309
Clinical summary
This test identifies mutations in the GABRB3 gene associated with childhood absence epilepsy type 5.
TEST-3982
GAD1 Gene Cerebral Palsy Type 1, Spastic Quadriplegic Genetic Test

This genetic test evaluates for pathogenic variants in the GAD1 gene associated with autosomal recessive spastic quadriplegic cerebral palsy type 1.

Blood, Extracted DNA, or FTA Card (Dried Blood Spot) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GAD1 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected GAD1-related cerebral palsy", "Family history of GAD1-related cerebral palsy", "Genetic counseling for families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G82.4
Clinical summary
This genetic test evaluates for pathogenic variants in the GAD1 gene associated with autosomal recessive spastic quadriplegic cerebral palsy type 1.
TEST-1280
Galactosemia (GALT) Gene Mutation Detection Test

This test identifies pathogenic variants in the GALT gene, confirming a diagnosis of classic galactosemia.

Whole Blood (EDTA Lavender Top Tube) 15 Business Days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GALT gene"]
Parameters
[]
Preparation
["No fasting or special preparation is needed."]
Indications
["Neonates with symptoms suggestive of galactosemia", "Newborns with positive newborn screening results", "Families with a known history of galactosemia", "Carrier screening for individuals with family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 32196-4 ICD-10: E74.21
Clinical summary
This test identifies pathogenic variants in the GALT gene, confirming a diagnosis of classic galactosemia.
TEST-1284
Galactosemia Panel 2 Test

This diagnostic test evaluates for inborn errors of galactose metabolism, specifically classic galactosemia, Duarte variant, and galactokinase deficiency.

Blood (Plasma) 5 Working Days 600.00 AED
View
View test specifications and preparation
What it measures
["Galactose-1-phosphate uridyltransferase (GALT)", "Related enzymes of galactose metabolism"]
Parameters
[{"name": "Galactose-1-phosphate uridyltransferase (GALT)", "reference_range": null}, {"name": "Galactokinase (GALK)", "reference_range": null}, {"name": "Galactose-6-phosphate isomerase (GPI)", "reference_range": null}]
Preparation
["Avoid alcohol and galactose-rich foods for 24 hours", "Provide a detailed list of medications and supplements", "Fasting is not mandatory"]
Indications
["Newborn screening follow-up", "Suspected galactosemia in infants or adults", "Diagnosis of classic galactosemia, Duarte variant, or galactokinase deficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 74520-7 ICD-10: E74.21
Clinical summary
This diagnostic test evaluates for inborn errors of galactose metabolism, specifically classic galactosemia, Duarte variant, and galactokinase deficiency.
TEST-1306
Galactosemia Panel 3 Test

This diagnostic test evaluates the activity of three key enzymes (GALT, GALK, GALE) involved in galactose metabolism.

Whole Blood 5 business days (digital report available) 550.00 AED
View
View test specifications and preparation
What it measures
["GALT (galactose-1-phosphate uridylyltransferase) enzyme activity", "GALK (galactokinase) enzyme activity", "GALE (UDP-galactose-4-epimerase) enzyme activity"]
Parameters
[{"name": "GALT (galactose-1-phosphate uridylyltransferase)", "reference_range": null}, {"name": "GALK (galactokinase)", "reference_range": null}, {"name": "GALE (UDP-galactose-4-epimerase)", "reference_range": null}]
Preparation
["No blood transfusion within the last 60 days", "Provide complete medication and clinical history", "Sample requires 4 mL of whole blood in a green-top sodium heparin tube"]
Indications
["Newborns with suspicious newborn screening results", "Infants presenting with prolonged jaundice, poor feeding, or failure to thrive", "Individuals with a family history of galactosemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 23731-3 ICD-10: E74.21
Clinical summary
This diagnostic test evaluates the activity of three key enzymes (GALT, GALK, GALE) involved in galactose metabolism.
TEST-4619
GALC Gene Krabbe Disease Genetic Test

This test evaluates the GALC gene for mutations associated with Krabbe disease.

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GALC gene", "Copy Number Variations (CNV) in the GALC gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Diagnostic confirmation of suspected Krabbe disease", "Carrier screening for individuals with family history", "Presymptomatic testing in at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94056-2 ICD-10: E75.23
Clinical summary
This test evaluates the GALC gene for mutations associated with Krabbe disease.
TEST-6311
GALK1 Gene Galactokinase Deficiency Genetic Test

This genetic test identifies pathogenic variants in the GALK1 gene, confirming galactokinase deficiency (galactosemia type II).

Whole Blood (EDTA tube), Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GALK1 gene", "Coding exons and splice junctions of the GALK1 gene", "Copy Number Variations (CNV)"]
Parameters
[]
Preparation
["No special preparation such as fasting is required.", "Continue all prescribed medications unless directed otherwise by your physician."]
Indications
["Suspected galactokinase deficiency", "Family history of galactosemia type II", "Screening for carrier status"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82304-8 ICD-10: E74.21
Clinical summary
This genetic test identifies pathogenic variants in the GALK1 gene, confirming galactokinase deficiency (galactosemia type II).

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area